ACTRN12610001046099进行中（未招募）2 期
Immune response and seroconversion in two-dose fractional inactivated poliovirus vaccine administered at 4 and 8 months of age
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 入组人数
- 320
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 4 Months 至 5 Months（—）
- 性别
- All
入选标准
- •Healthy infants (greater than 3rd percentile for height and weight) at enrollment living within the catchment area of
- •the participating polyclinics.
排除标准
- •Infants less than 3 percentile for height and weight, residence outside the catchment area, or families expecting
- •to move away during the study period, will be excluded. A diagnosis, suspicion or treatment of
- •immunodeficiency disorder (either in the participant or in a member of the immediate family) will render
- •the newborn ineligible for the study. Infants of mother age below legal age (<18 years) or with mentally
- •incapacity will not be eligible to participate.
研究者
相似试验
进行中（未招募）
1 期
Evaluation of immunological response following a revaccination with a non-conjugated pneumococcal vaccine boosted or not by a conjugated pneumococcal vaccine in splenectomised patients (SPLENEVAC-2)Asplenic patients at risk for invasive pneumococcal diseasesMedDRA version: 20.0Level: PTClassification code 10041642Term: SplenectomySystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2018-003068-29-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)56
已完成
不适用
Safety and immunogenicity of one and two doses of the live, attenuated oral ETEC candidate vaccine BB01 in healthy adults - a phase I, randomized, double-blind studyETEC disease.Infections and InfestationsEnterotoxigenic E. coli infectionISRCTN05087777Berna Biotech Ltd (Switzerland)50
进行中（未招募）
1 期
Immunological responses after concomitant vaccination with the yellow fever-vaccine and the TBE-vaccine, or JE-vaccinePrevention of TBE or Japanece encephalitis by co-vaccination with the yellow fever vaccineEUCTR2017-002137-32-SEHans-Gustaf Ljunggren140
尚未招募
不适用
Can vaccination produce protective antibodies in people who fail to develop protective antibodies after recovery from COVID-19 infectioCTRI/2021/04/032572Rajiv Gandhi Cancer Institute and Research Centre
已完成
不适用
Immune response of fractional doses of Inactivated Poliovirus Vaccine (IPV) administered intradermally in the Sultanate of OmaPoliomyelitis vaccinationInfections and InfestationsPoliomyelitisISRCTN17418767World Health Organization (WHO) (Switzerland)400